PMID: 6971560Jan 1, 1981Paper

Effect of antidepressants, lithium and electroconvulsive treatment on rat serum prolactin levels

Acta Psychiatrica Scandinavica. Supplementum
H Y MeltzerV S Fang

Abstract

The ability of antidepressant drugs, electroconvulsive treatment (ECT), or lithium chloride (LiCl), to modify prolactin secretion in the rat was studied. Chlorimipramine, citalopram, fluoxetine, imipramine and zimelidine potentiated the low dose 5-hydroxytryptophan (5-HTP)-induced increase in prolactin secretion, suggesting inhibition of serotonin (5-HT) uptake by these drugs. Amitriptyline, doxepin, iprindole, mianserin and trazadone inhibited the prolactin stimulating effects of high doses of 5-HTP and quipazine, suggesting that these drugs have 5-HT receptor blocking properties. Tandamine inhibited only 5-HTP-induced increase in prolactin secretion. Chronic administration of imipramine, potentiated the effect of low dose 5-HTP significantly more than an acute dose. Amitriptyline, produced similar inhibition of the 5-HTP-induced increase in prolactin secretion after both acute and chronic administration. The ability of bupropion and mazindol to inhibit alpha-methylparatyrosine-induced prolactin secretion, and of nomifensine to inhibit reserpine-induced prolactin secretion, is consistent with other evidence that these agents are indirect dopamine (DA) agonists. Desipramine, acutely, had no effect on any of the above paradigms ...Continue Reading

References

Jan 21, 1977·European Journal of Pharmacology·A V ChristensenO Svendsen
Dec 1, 1977·The Journal of Pharmacy and Pharmacology·F E SorokoD H Schroeder
Oct 1, 1979·The Journal of Pharmacy and Pharmacology·E Mogilnicka, V Klimek
Sep 15, 1978·Psychopharmacology·J MajA Rawłów
Jun 5, 1978·Life Sciences·H Y MeltzerV S Fang
Jan 1, 1978·Journal of Neural Transmission·A Carlsson, M Lindqvist
Oct 1, 1979·Proceedings of the Society for Experimental Biology and Medicine·D CocchiE E Müller
Dec 1, 1977·Pharmakopsychiatrie, Neuro-Psychopharmakologie·J MajA Rawłów
May 1, 1979·Pharmakopsychiatrie, Neuro-Psychopharmakologie·J MajA Rawtów
Jan 1, 1979·Journal of Neural Transmission·R W Fuller, H D Snoddy
Jan 1, 1979·Journal of Neural Transmission·J Maj Rawłów
Jan 1, 1978·Biochemical Pharmacology·M F Sugrue, S E Mireylees
Jan 1, 1976·Schizophrenia Bulletin·H Y Meltzer, S M Stahl
Oct 1, 1977·British Journal of Pharmacology·I GoodletM F Sugrue
Apr 1, 1976·European Journal of Pharmacology·F ZambottiP Mantegazza
Aug 1, 1976·European Journal of Pharmacology·C Braestrup, J Scheel-Krüger
Oct 1, 1976·Life Sciences·H Y MeltzerR Kaluskar
May 1, 1975·European Journal of Pharmacology·J B LassenS O Olsson
Sep 23, 1972·Lancet·D S JanowskyH J Sekerke
May 1, 1974·The Journal of Pharmacy and Pharmacology·P HuntJ Raynaud
Apr 1, 1974·Japanese Journal of Pharmacology·T Segawa, M Nakano
Jan 1, 1974·Archives of General Psychiatry·A J PrangeR A Stikeleather
Apr 1, 1974·Proceedings of the Society for Experimental Biology and Medicine·L GrandisonJ Meites
May 1, 1972·Archives of General Psychiatry·A CoppenR Noguera
Nov 1, 1965·The American Journal of Psychiatry·J J Schildkraut

❮ Previous
Next ❯

Citations

Apr 1, 1994·Pharmacology, Biochemistry, and Behavior·C S AulakhD L Murphy
Nov 1, 1984·Psychiatry Research·H M CalilW Z Potter
May 1, 1988·Psychiatry Research·L H PriceG R Heninger
Jan 1, 1990·Progress in Neuro-psychopharmacology & Biological Psychiatry·F P Zemlan, D L Garver
Nov 22, 1997·Journal of Psychiatric Research·E SeifritzE Holsboer-Trachsler
Sep 30, 1999·Life Sciences·D K Raap, L D Van de Kar
Jun 5, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·V GavrilovR H Belmaker
Jan 1, 1991·The Journal of Pharmacy and Pharmacology·R E Poland, A Frazer
Jan 1, 1982·Progress in Neuro-psychopharmacology & Biological Psychiatry·J Hyttel
Apr 21, 2001·The Journal of ECT·Y G PapakostasM Daras
Jan 1, 1990·Annals of the New York Academy of Sciences·H Y Meltzer
Oct 3, 1999·Journal of Clinical Psychopharmacology·P Popik
Jan 1, 1985·Acta Pharmacologica Et Toxicologica·J Hyttel, J J Larsen
Jun 10, 2020·Journal of Psychiatric Research·Georgios SchoretsanitisGeorgios Petrides

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.